Teva Pharmaceutical Financials
| TEVA Stock | ILA 6,135 205.00 3.23% |
Teva |
Understanding current and past Teva Pharmaceutical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Teva Pharmaceutical's financial statements are interrelated, with each one affecting the others. For example, an increase in Teva Pharmaceutical's assets may result in an increase in income on the income statement.
Please note, the presentation of Teva Pharmaceutical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Teva Pharmaceutical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Teva Pharmaceutical's management manipulating its earnings.
Teva Pharmaceutical Stock Summary
Teva Pharmaceutical competes with Bezeq Israeli, El Al, Bank Leumi, Elbit Systems, and Tower Semiconductor. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. TEVA PHARMA is traded on Tel Aviv Stock Exchange in Israel.| Foreign Associate | USA |
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0006290147 |
| Business Address | 124 Dvora HaNevia |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.tevapharm.com |
| Phone | (972) 3 914 8213 |
| Currency | ILA |
You should never invest in Teva Pharmaceutical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Teva Stock, because this is throwing your money away. Analyzing the key information contained in Teva Pharmaceutical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Teva Pharmaceutical Key Financial Ratios
Teva Pharmaceutical's financial ratios allow both analysts and investors to convert raw data from Teva Pharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of Teva Pharmaceutical over time and compare it to other companies across industries.| Return On Equity | -0.24 | |||
| Return On Asset | 0.0363 | |||
| Target Price | 11.0 | |||
| Beta | 1.22 | |||
| Z Score | 1.2 |
Teva Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Teva Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Teva Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Teva Pharmaceutical competition to find correlations between indicators driving Teva Pharmaceutical's intrinsic value. More Info.Teva Pharmaceutical Industries is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Teva Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Teva Pharmaceutical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Teva Pharmaceutical Systematic Risk
Teva Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Teva Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Teva Pharmaceutical correlated with the market. If Beta is less than 0 Teva Pharmaceutical generally moves in the opposite direction as compared to the market. If Teva Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Teva Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Teva Pharmaceutical is generally in the same direction as the market. If Beta > 1 Teva Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.
Teva Pharmaceutical November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Teva Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Teva Pharmaceutical Industries. We use our internally-developed statistical techniques to arrive at the intrinsic value of Teva Pharmaceutical Industries based on widely used predictive technical indicators. In general, we focus on analyzing Teva Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Teva Pharmaceutical's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.92 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 9.44 | |||
| Value At Risk | (3.32) | |||
| Potential Upside | 3.29 |
Complementary Tools for Teva Stock analysis
When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |